UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in IMVT — Immunovant, Inc.
CIK 861177
NEW YORK, NY
Position in IMVT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,434,876
+$914,356 QoQ
Shares Held
115,102
-18.8% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 226 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. IMVT ranks #67 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in IMVT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,434,876 | 115,102 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,520,520 | 141,728 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,417,487 | 134,441 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,728,448 | 107,224 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,204,160 | 200,260 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,394,151 | 140,091 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $6,917,068 | 279,252 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,861,760 | 310,830 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,461,408 | 320,508 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,656,859 | 206,031 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,744,162 | 207,552 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,183,142 | 82,916 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $981,164 | 51,722 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $802,206 | 51,722 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $776,632 | 43,754 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $208,385 | 37,345 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $202,572 | 51,942 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $286,198 | 51,942 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $442,544 | 51,942 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $451,374 | 51,942 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $636,281 | 60,197 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $698,493 | 43,547 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,061,967 | 44,641 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $703,800 | 20,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $216,715 | 8,900 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||